Galmed Pharmaceuticals Ltd. buy Morgan Stanley
Start price
15.07.25
/
50%
€6.40
Target price
15.07.26
€58.28
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 15.07.26. The prediction end date can be changed by Morgan_Stanley at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - |
| iShares Core DAX® | 0.760% | 1.149% |
| iShares Nasdaq 100 | 0.732% | 1.884% |
| iShares Nikkei 225® | 1.025% | -0.865% |
| iShares S&P 500 | -0.036% | 1.480% |
Comments by Morgan_Stanley for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target lowered by analysts at Morgan Stanley from $75.00 to $68.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Morgan_Stanley for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
02.12.24
02.12.24
€95.17
02.12.25
02.12.25
-
03.12.25
03.12.25
